Increases to CEO Compensation Might Be Put On Hold For Now at Mohini Health & Hygiene Limited (NSE:MHHL)

Key Insights

• Mohini Health & Hygiene will host its Annual General Meeting on 30th of September
• CEO Avnish Bansal's total compensation includes salary of ₹8.40m
• Total compensation is 52% above industry average
• Mohini Health & Hygiene's total shareholder return over the past three years was 44% while its EPS grew by 0.6% over the past three years

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Performance at Mohini Health & Hygiene Limited (NSE:MHHL) has been reasonably good and CEO Avnish Bansal has done a decent job of steering the company in the right direction. In light of this performance, CEO compensation will probably not be the main focus for shareholders as they go into the AGM on 30th of September. However, some shareholders may still want to keep CEO compensation within reason.

Check out our latest analysis for Mohini Health & Hygiene

How Does Total Compensation For Avnish Bansal Compare With Other Companies In The Industry?

At the time of writing, our data shows that Mohini Health & Hygiene Limited has a market capitalization of ₹946m, and reported total annual CEO compensation of ₹8.4m for the year to March 2025. This was the same amount the CEO received in the prior year. It is worth noting that the CEO compensation consists entirely of the salary, worth ₹8.4m.

On comparing similar-sized companies in the India Medical Equipment industry with market capitalizations below ₹18b, we found that the median total CEO compensation was ₹5.5m. Hence, we can conclude that Avnish Bansal is remunerated higher than the industry median.

Speaking on an industry level, all of total compensation represents salary, while non-salary remuneration is completely ignored. Speaking on a company level, Mohini Health & Hygiene prefers to tread along a traditional path, disbursing all compensation through a salary. If total compensation veers towards salary, it suggests that the variable portion - which is generally tied to performance, is lower.

A Look at Mohini Health & Hygiene Limited's Growth Numbers

Earnings per share at Mohini Health & Hygiene Limited are much the same as they were three years ago, albeit with slightly higher. In the last year, its revenue is down 16%.

We would argue that the lack of revenue growth in the last year is less than ideal, but the modest improvement in EPS is good. These two metrics are moving in different directions, so while it's hard to be confident judging performance, we think the stock is worth watching. While we don't have analyst forecasts for the company, shareholders might want to examine this detailed historical graph of earnings, revenue and cash flow.

Has Mohini Health & Hygiene Limited Been A Good Investment?

Most shareholders would probably be pleased with Mohini Health & Hygiene Limited for providing a total return of 44% over three years. As a result, some may believe the CEO should be paid more than is normal for companies of similar size.

To Conclude...

Mohini Health & Hygiene pays CEO compensation exclusively through a salary, with non-salary compensation completely ignored. The company's decent performance might have made most shareholders happy, possibly making CEO remuneration the least of the concerns to be discussed in the upcoming AGM. However, if the board proposes to increase the compensation, some shareholders might have questions given that the CEO is already being paid higher than the industry.

CEO compensation is a crucial aspect to keep your eyes on but investors also need to keep their eyes open for other issues related to business performance. That's why we did some digging and identified 3 warning signs for Mohini Health & Hygiene that you should be aware of before investing.

Important note: Mohini Health & Hygiene is an exciting stock, but we understand investors may be looking for an unencumbered balance sheet and blockbuster returns. You might find something better in this list of interesting companies with high ROE and low debt.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.